“We aim to recruit 50 patients by summer next year with the expectation that we can be phase three ready in that study by the end of next year.”
→ Read the source episode
StepPharma recruits 50 patients in ET phase 2 trial by 2027-06-30 and achieves phase three readiness by 2027-12-31
Tony Hixson predicts See Further will announce more pediatric cancer programs before end of 2026
Jean Mack predicts Phase 2 will enroll patients across Australia, potentially Europe, and the United States
Deborah Research will identify and move the most promising read-through molecule candidates into first-in-human clinical studies.
Deborah Research is supporting development of a self-cooling sole for sneakers to address blister problems in EB patients.
Lu Gao predicts Therona will file INDs in parallel in the US and China in Q4 2026
Jean Mack predicts GAIN's IND will be cleared by the FDA within weeks and Phase 2 will begin in Q3 2026
Summaries are ours; the quote is a verbatim transcript excerpt. Our resolution criteria are editorial and disputable. How this works.